CLARITY BEFORE DECISIONS
Understand your options.
Estrogen treatment may be systemic or local. The route and product affect what symptoms it addresses and its risks.
At Thrive, treatment conversations begin with your goals and a medical evaluation. Choosing to explore a service does not commit you to treatment.
YOUR HEALTH COMES FIRST
Who may consider an evaluation?
People with bothersome menopause symptoms can discuss treatment after review of bleeding, cancer history, clotting history, cardiovascular risks, and preferences.
Share sensitive health details through the clinic’s appropriate clinical intake process, rather than a general website questionnaire.
Potential benefits.
Realistic expectations.
Appropriately selected therapy can reduce hot flashes; some vaginal products address vaginal symptoms. Product-specific benefits differ.
Important limitations
Exact available products, formulations, and routes must be confirmed with Thrive. FDA-approved products and compounded preparations are different. Compounded hormones are not FDA-approved, and “bioidentical” does not establish greater safety or effectiveness.
INFORMED CARE
Make room for the safety conversation.
Depending on product and patient, risks include blood clots, stroke, gallbladder disease, and certain cancers. Unexplained vaginal bleeding and pregnancy require evaluation before treatment.
This is an educational overview, not complete safety information. Your clinician should review current product labeling, your medical history, and alternatives before treatment. Do not start, stop, or adjust a prescription based on this page.
What to expect.
Compare systemic and local approaches. People with a uterus generally require endometrial protection with systemic estrogen; the provider determines an appropriate regimen.
- Start with your priorities. Discuss your goals and the concerns you want to understand.
- Review the details. Ask about evidence, alternatives, expected recovery, risks, and total cost.
- Agree on the next step. If treatment is appropriate, your provider explains the plan and follow-up.
Cherry, CareCredit, and eligible Affirm options are subject to approval and applicable terms. HSA/FSA use depends on the service and your plan. Financing does not establish medical eligibility.
A MORE INFORMED START
Your questions, answered.
Is hormone therapy appropriate for everyone?
No. Symptoms, diagnosis, medical history, preferences, and the risks of a particular product determine the next step.
Are compounded hormones safer?
FDA has not established that compounded hormone therapy is safer or more effective than FDA-approved options.
Will I need follow-up?
If therapy is prescribed, monitoring is individualized to the product, condition, and clinical response.
Can I request a telehealth consultation?
Appropriate telehealth consultations may be available. The clinic confirms whether your needs, location, and applicable examination or prescribing requirements allow a remote visit.
Can I use financing or HSA/FSA funds?
Explore Thrive’s payment options. Financing approval and eligible expenses depend on the provider, service, and your individual plan.
Continue exploring.
Testosterone replacement evaluation ↗
For additional background on the evidence and safety considerations discussed above, read FDA: menopause and hormone therapy. Your provider reviews the latest applicable information before care.
Treatment options are determined by a licensed medical provider following an individualized evaluation. Results vary, and not all treatments are appropriate for every patient.